tiprankstipranks
AegirBio AB (SE:SUBGEN)
:SUBGEN
Sweden Market
SUBGEN
AegirBio AB
RESEARCH TOOLSreports
Want to see SE:SUBGEN full AI Analyst Report?

AegirBio AB (SUBGEN) Financial Statements

1 Followers

AegirBio AB Financial Overview

AegirBio AB's market cap is currently kr74.11M. The company's EPS TTM is kr-0.1098; its P/E ratio is -0.34; AegirBio AB is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 204.39Mkr 203.76Mkr 92.00Kkr 1.71Mkr 13.28M
Gross Profitkr 75.16Mkr -14.27Mkr 44.00Kkr -23.71Mkr 5.51M
Operating Incomekr -129.21Mkr -36.55Mkr -56.16Mkr -91.48Mkr -83.76M
EBITDAkr -104.63Mkr -27.02Mkr -34.67Mkr -351.78Mkr -74.20M
Net Incomekr -88.88Mkr -49.63Mkr -59.70Mkr -362.83Mkr -92.33M
Balance Sheet
Cash & Short-Term Investmentskr 18.74Mkr 283.00Kkr 12.14Mkr 14.59Mkr 34.03M
Total Assetskr 617.77Mkr 32.61Mkr 53.10Mkr 66.87Mkr 404.37M
Total Debtkr 102.41Mkr 45.48Mkr 32.72Mkr 7.58Mkr 9.83M
Net Debtkr 83.67Mkr 45.20Mkr 20.58Mkr -7.43Mkr -24.20M
Total Liabilitieskr 200.62Mkr 71.25Mkr 54.55Mkr 27.04Mkr 33.95M
Stockholders' Equitykr 418.65Mkr -38.65Mkr -1.45Mkr 39.83Mkr 370.42M
Cash Flow
Free Cash Flowkr -20.59Mkr -12.58Mkr -47.52Mkr -49.06Mkr -109.37M
Operating Cash Flowkr -12.56Mkr -12.57Mkr -41.99Mkr -49.00Mkr -109.37M
Investing Cash Flowkr -66.47Mkr -15.55Mkr -5.54Mkr -65.00Kkr 1.60M
Financing Cash Flowkr 89.26Mkr 16.24Mkr 45.05Mkr 29.26Mkr 130.25M
Currency in SEK

AegirBio AB Earnings and Revenue History

Income Statement >

AegirBio AB Debt to Assets

Balance Sheet >

AegirBio AB Cash Flow

Cash Flow >

AegirBio AB Forecast EPS vs Actual EPS

Earnings >